中国循环杂志
中國循環雜誌
중국순배잡지
CHINESE CIRCULATION JOURNAL
2014年
11期
875-878
,共4页
张龙%钱海燕%武德巍%郑磊%张丽%俞梦越
張龍%錢海燕%武德巍%鄭磊%張麗%俞夢越
장룡%전해연%무덕외%정뢰%장려%유몽월
稳定性心绞痛%糖尿病%血栓弹力图%花生四烯酸抑制率%二磷酸腺苷抑制率
穩定性心絞痛%糖尿病%血栓彈力圖%花生四烯痠抑製率%二燐痠腺苷抑製率
은정성심교통%당뇨병%혈전탄력도%화생사희산억제솔%이린산선감억제솔
Stable angina pectoris%Diabetes mellitus%Thromboelastography%Arachidonic acid inhibition rate%Adenosine diphosphate inhibition rate
目的:分析合并2型糖尿病的稳定性心绞痛患者血栓弹力图检测结果。<br> 方法:随机抽取阜外心血管病医院2012-01至2013-06行冠状动脉造影并置入支架的稳定性心绞痛患者360例,按照是否合并2型糖尿病分为糖尿病组(n=109)和非糖尿病组(n=251),两组患者经常规术前检查、药物治疗和冠状动脉支架置入,入院后行常规检查及血栓弹力图检测。分析血栓弹力图各指标在两组间的差异。<br> 结果:糖尿病组年龄、男性占比例、高血压病史占比例、高脂血症占比例和高敏C反应蛋白显著高于非糖尿病组(P<0.05),单因素回归分析显示,糖尿病与二磷酸腺苷抑制率显著相关(r=0.977,P=0.0001),与花生四烯酸抑制率相关性不显著(r=0.245,P=0.069);多因素回归分析显示,在控制上述组间有统计学差异的各因素之后,糖尿病与二磷酸腺苷抑制率仍显著相关(r=0.862,P=0.0001)。两组患者的血栓弹力图主要参数,包括R值、K值、α角和Ma值均有显著统计学差异(P<0.05);花生四烯酸抑制率在两组间无显著差异(P=0.057),而二磷酸腺苷抑制率在两组有显著统计学差异(P=0.0001);且糖尿病组氯吡格雷抵抗的发生率显著高于非糖尿病组(34.7%vs 16.2%,P=0.001)。<br> 结论:合并糖尿病的稳定性心绞痛患者呈现高凝状态,且氯吡格雷抵抗发生率高,提示冠状动脉介入术后需要加强抗血小板治疗以减少心血管事件。
目的:分析閤併2型糖尿病的穩定性心絞痛患者血栓彈力圖檢測結果。<br> 方法:隨機抽取阜外心血管病醫院2012-01至2013-06行冠狀動脈造影併置入支架的穩定性心絞痛患者360例,按照是否閤併2型糖尿病分為糖尿病組(n=109)和非糖尿病組(n=251),兩組患者經常規術前檢查、藥物治療和冠狀動脈支架置入,入院後行常規檢查及血栓彈力圖檢測。分析血栓彈力圖各指標在兩組間的差異。<br> 結果:糖尿病組年齡、男性佔比例、高血壓病史佔比例、高脂血癥佔比例和高敏C反應蛋白顯著高于非糖尿病組(P<0.05),單因素迴歸分析顯示,糖尿病與二燐痠腺苷抑製率顯著相關(r=0.977,P=0.0001),與花生四烯痠抑製率相關性不顯著(r=0.245,P=0.069);多因素迴歸分析顯示,在控製上述組間有統計學差異的各因素之後,糖尿病與二燐痠腺苷抑製率仍顯著相關(r=0.862,P=0.0001)。兩組患者的血栓彈力圖主要參數,包括R值、K值、α角和Ma值均有顯著統計學差異(P<0.05);花生四烯痠抑製率在兩組間無顯著差異(P=0.057),而二燐痠腺苷抑製率在兩組有顯著統計學差異(P=0.0001);且糖尿病組氯吡格雷牴抗的髮生率顯著高于非糖尿病組(34.7%vs 16.2%,P=0.001)。<br> 結論:閤併糖尿病的穩定性心絞痛患者呈現高凝狀態,且氯吡格雷牴抗髮生率高,提示冠狀動脈介入術後需要加彊抗血小闆治療以減少心血管事件。
목적:분석합병2형당뇨병적은정성심교통환자혈전탄력도검측결과。<br> 방법:수궤추취부외심혈관병의원2012-01지2013-06행관상동맥조영병치입지가적은정성심교통환자360례,안조시부합병2형당뇨병분위당뇨병조(n=109)화비당뇨병조(n=251),량조환자경상규술전검사、약물치료화관상동맥지가치입,입원후행상규검사급혈전탄력도검측。분석혈전탄력도각지표재량조간적차이。<br> 결과:당뇨병조년령、남성점비례、고혈압병사점비례、고지혈증점비례화고민C반응단백현저고우비당뇨병조(P<0.05),단인소회귀분석현시,당뇨병여이린산선감억제솔현저상관(r=0.977,P=0.0001),여화생사희산억제솔상관성불현저(r=0.245,P=0.069);다인소회귀분석현시,재공제상술조간유통계학차이적각인소지후,당뇨병여이린산선감억제솔잉현저상관(r=0.862,P=0.0001)。량조환자적혈전탄력도주요삼수,포괄R치、K치、α각화Ma치균유현저통계학차이(P<0.05);화생사희산억제솔재량조간무현저차이(P=0.057),이이린산선감억제솔재량조유현저통계학차이(P=0.0001);차당뇨병조록필격뢰저항적발생솔현저고우비당뇨병조(34.7%vs 16.2%,P=0.001)。<br> 결론:합병당뇨병적은정성심교통환자정현고응상태,차록필격뢰저항발생솔고,제시관상동맥개입술후수요가강항혈소판치료이감소심혈관사건。
Objective: To analyze the thromboelastography (TEG) outcomes in patients with stable angina pectoris (SAP) combining diabetes mellitus (DM). <br> Methods: A total of 360 SAP patients treated in our hospital by percutaneous coronary intervention (PCI) from 2012-01 to 2013-06 were randomized into 2 groups:SAP+DM group, n=109 and SAP-DM group, n=251. Routine clinical examination and TEG test were performed and compared between 2 groups. <br> Results: Compared with SAP-DM group, SAP+DM group showed the higher ratios of male gender, history of hypertension, hyperlipidemia and higher level of hs-CRP, all P<0.05. Single regression analysis indicated that DM was related to adenosine diphosphate (ADP) inhibition rate (r=0.977, P=0.0001), not related to arachidonic acid (AA) inhibition rate (r=0.245, P=0.069). Multi regression analysis presented that with controlled relevant factors, DM was still related to ADP inhibition rate (r=0.862, P=0.0001). The major TEG parameters as R value, K value,α-angle and MA value were obviously different between 2 groups, P<0.05, while the AA inhibition rate was similar, P=0.057. ADP inhibition rate was different between 2 groups, P=0.0001. The incidence of clopidogrel resistance was higher in SAP+DM group than that in SAP-DM group (34.7%vs 16.2%, P=0.001). <br> Conclusion: The SAP patients combining DM were at hyper-coagulation status with higher incidence of clopidogrel resistance, who needed intensive post-operative anti-platelet therapy.